Sugi Predict

Sugi Predict / Compounds / SCHEMBL845645

SCHEMBL845645

SCHEMBL845645

CC(=O)OC[C@@H](O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H](C=O)OC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.47
▸ USP2 O75604 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ABCB1 P08183 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3489131 1.00 TDP1 (0.47) TDP1USP2CYP3A4MAPTSMN1; SMN2
SCHEMBL669311 1.00 TDP1 (0.47) TDP1USP2CYP3A4MAPTSMN1; SMN2
SCHEMBL28554669 1.00 TDP1 (0.47) TDP1USP2CYP3A4MAPTSMN1; SMN2
Bromide SCHEMBL1290055 0.98 TDP1 (0.46) TDP1USP2CYP3A4MAPTSMN1; SMN2
Bromide SCHEMBL1290128 0.98 TDP1 (0.46) TDP1USP2CYP3A4MAPTSMN1; SMN2
SCHEMBL9679260 0.95 TDP1 (0.49) TDP1USP2CYP3A4MAPTSMN1; SMN2
Propanol SCHEMBL4985613 0.93 TDP1 (0.41) TDP1
SCHEMBL6234229 0.89 TDP1 (0.46) TDP1USP2CYP3A4MAPTSMN1; SMN2
SCHEMBL17276716 0.86 TSHR (0.44) TDP1CYP3A4ALDH1A1HPGD
SCHEMBL9737328 0.85 TDP1 (0.46) TDP1USP2CYP3A4MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114736315-B Method for synthesizing heptasaccharide of lentinan core fragment beta- (1 → 6) branched chain beta- (1 → 3) main chain 艾立斯特(合肥)生物科技有限公司 2023-03-17 — — CN claimed
CN-114736315-A Heptasaccharide synthesis method of lentinan core fragment beta- (1 → 6) branched chain beta- (1 → 3) main chain 艾立斯特(合肥)生物科技有限公司 2022-07-12 — — CN claimed
CN-114409817-A Heptasaccharide synthesis method of lentinan core fragment beta- (1 → 6) branched chain beta- (1 → 3) main chain 艾立斯特(合肥)生物科技有限公司 2022-04-29 — — CN claimed
US-8278436-B2 Glycosylated warfarin analogs and uses thereof WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2012-10-02 — — US claimed
US-20100267655-A1 Glycosylated Warfarin Analogs and Uses Thereof WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-10-21 — — US claimed
WO-2010014814-A2 GLYCOSYLATED WARFARIN ANALOGS AND USES THEREOF WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-02-04 — — WO claimed
JP-60069093-A — — None — — JP disclosed
JP-3190893-A — — None — — JP disclosed
US-20260078141-A1 8-FLUORO-4-ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDE, BIOLOGICAL STERILIZATION INDICATOR INCLUDING THE SAME AND ITS USE IN A METHOD OF DETERMINING EFFICACY OF A STERILIZATION PROCESS SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2026-03-19 — — US disclosed
CN-109553653-B Panaxadiol glycoside derivative and preparation method and application thereof 苏州济尔生物医药有限公司 2024-04-09 — — CN disclosed
US-20240065990-A1 METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID BELLUS HEALTH INC (CA) 2024-02-29 — — US disclosed
EP-3851447-B1 METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID BELLUS HEALTH INC (CA) 2023-09-06 — — EP disclosed
CN-116425809-A Preparation method of fluorosugar 复旦大学 2023-07-14 — — CN disclosed
US-4719272-A FOR CATIONIC POLYSACCHARIDE GRAFT POLYMERS NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1988-01-12 — — US disclosed
US-4673707-A REACTING SYNTHETIC POLYMERS WITH HALOHYDRIN GLYCOSIDE OF SACCHARIDES NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1987-06-16 — — US disclosed
JP-S6069093-A PRODUCTION OF ACYL DERIVATIVE OF 1-OH ALDOSE NOGUCHI KENKYUSHO 1985-04-19 — — JP disclosed
US-4305932-A 1-Acylethoxyquin compounds and compositions for treating vitamin E-deficiency ABIC LTD. (IL) 1981-12-15 — — US disclosed
US-4200738-A Method for preparing auranofin SMITHKLINE CORPORATION (US) 1980-04-29 — — US disclosed
US-4131732-A Method for preparing auranofin SMITHKLINE CORPORATION (US) 1978-12-26 — — US disclosed
US-4122092-A Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone UNIVERSITY OF ROCHESTER (US) 1978-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240065990-A1 METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID APP, PSEN1, PSEN2 TDP1 402/4885USP2 1487/4885CYP3A4 1411/4885
US-20100267655-A1 Glycosylated Warfarin Analogs and Uses Thereof GPI, UGGT1, GALE TDP1 3781/4885USP2 4524/4885CYP3A4 230/4885
US-20260078141-A1 8-FLUORO-4-ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDE, BIOLOGICAL STERILIZATION INDICATOR INCLUDING THE SAME AND ITS USE IN A METHOD OF DETERMINING EFFICACY OF A STERILIZATION PROCESS ALPG, UNG, UGDH TDP1 1134/4885USP2 140/4885CYP3A4 272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.